🔴 NBIS is trading 4% down today amid broader market declines and geopolitical tensions

NBIS is trading at $97.80 (-4.07%) in pre-market, tracking a broader market sell-off fueled by escalating US-Iran tensions and US futures weakness.

• Major indices are trading significantly lower, with the S&P 500 down 1.14% and the NASDAQ dropping 1.48% as geopolitical risks weigh on investor sentiment.
• No company-specific news, earnings reports, or catalysts have been identified for NBIS as of April 2, 2026; the move appears strictly correlated with macro-level volatility.
• The decline follows developments from April 1, impacting sentiment across the biotech sector and the wider equity market.